Vivo Capital Fund VIII, L.P.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Aug 16, 2022
- Accession no.
- 0001213900-22-048763
- Filed
- Aug 16, 2022, 8:44 PM ET
- Trade date
- Aug 12-16, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $6.98M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vivo Capital Fund VIII, L.P.CIK 0001618788 | 10% Owner |
| Vivo Capital VIII, LLCCIK 0001618789 | 10% Owner |
| Vivo Capital Surplus Fund VIII, L.P.CIK 0001628048 | 10% Owner |
| Vivo Opportunity, LLCCIK 0001728970 | 10% Owner |
| Vivo Opportunity Fund Holdings, L.P.CIK 0001930214 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Stock | PPurchaseAcquired | +1,123,021 | $2.98 | +$3,346,602.58 | 1,480,374 | Indirect | Duplicate filing |
| Aug 15, 2022 | Common Stock | PPurchaseAcquired | +1,218 | $2.99 | +$3,641.82 | 1,481,592 | Indirect | Duplicate filing |
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +1,500,000 | $2.42 | +$3,630,000 | 2,981,592 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | PPurchaseAcquired | +1,500,000 | $2.42 | +$3,629,850 | 1,500,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.